Council for europe portal
Language : en Search
Choose language

Newsroom

European Pharmacopoeia / International harmonisation | News | 18 October 2021 | Strasbourg, France
The Pharmacopoeial Discussion Group (PDG), which brings together the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP), with the World Health Organization (WHO) as an observer, is preparing a pilot to integrate additional world pharmacopoeias. This is a critical step in the PDG’s commitment to expanding recognition of harmonised...
European Pharmacopoeia / Monograph | News | 14 October 2021 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) is seeking stakeholder feedback on the revised general chapter on Osmolality (2.2.35), published in this quarter’s issue of Pharmeuropa (33.4) for comment (deadline 31 December 2021).
European Pharmacopoeia / Monograph | News | 06 October 2021 | Strasbourg, France
A new draft monograph, Oxygen (98 per cent) (3098), has been published for comment in this quarter’s issue of Pharmeuropa (33.4), the European Pharmacopoeia (Ph. Eur.) online forum. The deadline for comments on the new monograph is 31 December 2021.
European Pharmacopoeia / Monograph | News | 04 October 2021 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Supplement 10.7 is now available and will be applicable in 39 European countries as of 1 April 2022.
European Pharmacopoeia / Ph. Eur. Commission | News | 03 September 2021 | Strasbourg, France
At its 168th session (November 2020), the European Pharmacopoeia (Ph. Eur.) Commission adopted a new general chapter: Balances for analytical purposes (2.1.7). This new chapter is included in Supplement 10.6 of the Ph. Eur., published in July 2021.
European Pharmacopoeia / Biological standardisation programme (BSP) | News | 03 August 2021 | Strasbourg, France
Following the successful completion of the BSP090 study on recombinant major allergens, in collaboration with project leaders from the Paul-Ehrlich-Institut, an article on one of the major study outcomes “Validation of a candidate European Pharmacopoeia standard method for quantification of major grass pollen allergen Phl p 5” has recently been published in the scientific journal Allergy.
EDQM / Job opportunities | News | 22 July 2021 | Strasbourg, France
Do you have experience in chemical hazard classification and Safety Data Sheet (SDS) requirements? Are you detail-oriented and able to work under pressure and meet deadlines? Do you have the excellent written and oral communication skills required to gather and provide technical information to users? Would you like to contribute to the activities of an International Organisation working for human...
EDQM / Job opportunities | News | 22 July 2021 | Strasbourg, France
Do you have professional media or communications experience, including drafting press releases, social media news and responding to journalist requests, gained in a medical/scientific setting? Alternatively, do you have a scientific background with professional media or communications experience?  Would you be able to lead a team in implementing the EDQM’s communications strategy promoting the...
EDQM / Job opportunities | News | 22 July 2021 | Strasbourg, France
Do you have a diploma in pharmacy, chemistry, biochemistry, biology or Quality Management Systems (QMS) with professional experience in QMS? Do you have the capacity to use your quality skills in the EDQM’s scientific-focused entities? Are teamwork, client orientation and analytical thinking part of your key skill set? Are you ready to play a critical role in maintaining a “Quality Culture”...
European Pharmacopoeia / Monograph | News | 12 July 2021 | Strasbourg, France
A new draft monograph, Golimumab concentrated solution (3103), has been published in this quarter’s issue of Pharmeuropa (33.3), the European Pharmacopoeia (Ph. Eur.) online forum for comment.
European Pharmacopoeia / Public enquiry | News | 09 July 2021 | Strasbourg, France
The revised general chapter Chemometric methods applied to analytical data (5.21) has been published in this quarter’s issue of Pharmeuropa (33.3), the European Pharmacopoeia (Ph. Eur.) online forum, for comment.
European Pharmacopoeia / Ph. Eur. Commission | News | 08 July 2021 | Strasbourg, France
At its 170th plenary session on 22-23 June 2021, the European Pharmacopoeia Commission decided to suspend the Gonadotrophin, equine serum, for veterinary use (0719) monograph. This means that as of Supplement 10.8, the monograph in question will no longer be part of the Ph. Eur. but will nonetheless remain on the Ph. Eur. work programme until a final decision can be made concerning its fate.
EDQM | News | 06 July 2021 | Strasbourg, France
The 2020 annual report of the European Directorate for the Quality of Medicines & HealthCare (EDQM) is now available, providing a comprehensive overview of its activities, achievements and events.
Products and Services | News | 05 July 2021 | Strasbourg, France
All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 33.3 is 30 September 2021.
European Pharmacopoeia / Ph. Eur. Commission | News | 02 July 2021 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission held its 170th session on 22 and 23 June 2021. As the decision-making body of the Ph. Eur., the Commission adopted 69 texts that will be published in Ph. Eur. Supplement 10.8 and be effective as of 1 July 2022.